70 likes | 89 Views
They are more likely to advance nutritional disorders as well as to fall prey to other diseases that affect their capacity to absorb nutrients from their diet.
E N D
Medical Foods Market To Reach USD 29.54 Billion By 2026 www.reportsanddata.com sales@reportsanddata.com
Market Summary Based on current analysis the global medical foods market was valued at USD 17.27 billion in 2018 and is expected to reach USD 29.54 billion by 2026, at a CAGR 6.9% Medical foods are planned for specific dietary management of a disease or a condition for which distinctive nutritional requirements, based on recognized scientific principles are established by medical evaluation. It is mandatory to consume medical foods under the supervision of a physician. Medical foods are to be consumed or administered enterally.
Our Approach Market Summary Specially formulated and intended for the dietary management of a disease that has distinctive nutritional needs that cannot be met by normal diet alone are known to be medical foods. Medical foods are not required to undergo premarket review or approval by FDA. Besides, they are relieved from the labeling requirements for health claims and nutrient content claims under the Nutrition Labeling and Education Act of 1990. Medical foods are customized for both pediatric and adult use and are available in a variety of forms, including powders, liquids, capsules, tablets, and bars. Moreover, they are specialized blends of macronutrients, vitamins, minerals, phytochemicals, and botanicals or preparations composed of a single nutrient. Companies profiled for this market study Protruding players operating in the market include Danone, Primus Pharmaceuticals, Inc., Nestlé, Abbott, Meiji Holdings and Co., Targeted Medical Pharma, Inc., Mead Johnson & Company, LLC., Accera, Inc., and Alfasigma. Get a Free Sample PDF Report to understand our report before you purchase:https://www.reportsanddata.com/sample-enquiry-form/1491
Our Approach Market Summary Key findings from the report Due to high disease prevalence, diabetic neuropathy held the largest market share of 51.1% in 2018. Also, chronic kidney disorder is expected to emerge with the fastest CAGR of 6.6% In the United States, Alzheimer is the 6th leading cause of death. An estimated 5.8 million Americans of all ages are living with Alzheimer's dementia in 2019. This number includes an estimated 5.6 million people age 65 and older and roughly 200,000 individuals under age 65 who have younger-onset Alzheimer’s Worldwide, 300 million people of all ages are suffering from depression. Depression is termed to be leading cause of disability around the world and is a key contributor to the overall global burden of disease To identify the key trends in the industry, click on the link below:https://www.reportsanddata.com/report-detail/medical-foods-market
Our Approach Market Summary Type (Revenue in USD Million; 2016–2026) Pills and tablets Powder Others Applications (Revenue in USD Million; 2016–2026) Chronic kidney disease Minimal hepatic encephalopathy Chemotherapy-induced diarrhea Pathogen-related infections Diabetic neuropathy ADHD Depression Alzheimer's disease Other
Our Approach Market Summary Route of Administration (Revenue in USD Million; 2016–2026) Oral Enteral Sales Channel (Revenue in USD Million; 2016–2026) Online Sales Institutional Sales Retail Sales Do you have questions about the Report or want to inquire about a Discount? Ask our Expert: https://www.reportsanddata.com/discount-enquiry-form/1491
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Our Approach About Us